Search
for
Sort by
Research 421–450 of 1000+
- WNT10A Mutations Are a Frequent Cause of a Broad Spectrum of Ectodermal Dysplasias with Sex-Biased Manifestation Pattern in Heterozygotes
- The PDGF/PDGFR pathway as a drug target
- Guidelines for the management of alopecia areata
- Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice
- Functional salivary gland regeneration by transplantation of a bioengineered organ germ
- Prostaglandin-Induced Hair Growth
- The pharmacology of methotrexate
- Caffeine’s Mechanisms of Action and Its Cosmetic Use
- Lupus erythematosus: systemic and cutaneous manifestations
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- In vivo and in vitro evaluation of hair growth potential of Hibiscus rosa-sinensis Linn.
- Drug-Induced Skin, Nail and Hair Disorders
- Keratin disorders: from gene to therapy
- The human hair: from anatomy to physiology
- Surface Lipids as Multifunctional Mediators of Skin Responses to Environmental Stimuli
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Prolactin and the Skin: A Dermatological Perspective on an Ancient Pleiotropic Peptide Hormone
- Beyond acne: Current aspects of sebaceous gland biology and function
- Male Pattern Alopecia A Histopathologic and Histochemical Study
- Melanocytes: The new Black
- Obesity and polycystic ovary syndrome
- Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Molecular basis of hypohidrotic ectodermal dysplasia: an update
- Alopecia Areata Update
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Cutaneous lupus erythematosus
- Toxic Epidermal Necrolysis